Effect of Tribulus Terrestris in the Treatment of Female Sexual Dysfunction and Clitoral Vascularization. Results of a Randomized Study Comparing Two Different Dosage Regimes

التفاصيل البيبلوغرافية
العنوان: Effect of Tribulus Terrestris in the Treatment of Female Sexual Dysfunction and Clitoral Vascularization. Results of a Randomized Study Comparing Two Different Dosage Regimes
المؤلفون: Fabiene Bernardes Castro Vale, Gerson Pereira Lopes, Selmo Geber, Guilherme Primo Geber, Junia Duelli Boroni, Enylda Motta Gonçalves Antunes, Tancredo Bretas
المصدر: Journal of Sex & Marital Therapy. 47:696-706
بيانات النشر: Informa UK Limited, 2021.
سنة النشر: 2021
مصطلحات موضوعية: 050103 clinical psychology, medicine.medical_specialty, Tribulus terrestris, media_common.quotation_subject, Female sexual dysfunction, Urology, Orgasm, Clitoris, law.invention, 03 medical and health sciences, 0302 clinical medicine, Sex hormone-binding globulin, Randomized controlled trial, law, Tribulus, medicine, Humans, 0501 psychology and cognitive sciences, Sexual Dysfunctions, Psychological, media_common, 030219 obstetrics & reproductive medicine, biology, business.industry, 05 social sciences, Testosterone (patch), medicine.disease, Prolactin, Sexual Dysfunction, Physiological, Clinical Psychology, Sexual dysfunction, biology.protein, Female, medicine.symptom, business
الوصف: We evaluated the efficacy of Tribulus terrestris in two different dosage regimes for the treatment of sexual dysfunction in pre and postmenopausal women and its effect on the vascular resistance of the clitoral artery using Power Doppler. A total of 104 women were randomly assigned to receive 94mg, three times/day (TT3) or 280mg once/day for 90 days (TT1). Evaluation was performed using FSFI and QS-F questionnaires, serum levels of prolactin, TSH, total testosterone and SHBG, and clitoral artery assessment with Power Doppler ultrasound. FSFI results demonstrated an improvement in all domains in both groups (P < 0.05) except for the "Satisfaction" in the TT3 premenopausal group. QS-F results showed a significant improvement in the mean total score in women of both reproductive phases, for both groups. Postmenopausal patients improved in all sexual domains, except for "orgasm" in the TT1 group. PI of the clitoral artery showed no difference in both reproductive phases, in both groups. We conclude that TTerrestris can be a safe alternative for the treatment of sexual dysfunction in pre and postmenopausal women as it is effective in reducing the symptoms with no side effects. Moreover, its use, increased total, free and bioavailable testosterone.
تدمد: 1521-0715
0092-623X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3161c12ad6d1917b87d032409c0743f4
https://doi.org/10.1080/0092623x.2021.1938764
رقم الأكسشن: edsair.doi.dedup.....3161c12ad6d1917b87d032409c0743f4
قاعدة البيانات: OpenAIRE